ClinicalTrials.gov
public full text
Public Domain
Phase 1 TAK-915 Single-Dose Positron Emission Tomography (PET) Occupancy Study
This phase 1 study will be conducted to examine the degree and duration of brain PDE2A enzyme occupancy /target engagement as a function of TAK-915 plasma concentration in order to guide dosing and schedule for future clinical studies in schizophrenia with TAK-915.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging#813799
- Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases#860300
- 258. Metabolic connectomics and brain dynamics in schizophrenia: a novel perspective on treatment resistance and clinical response#784450
- The Brain Metabolic Change in Chronic Cancer Pain Patient: FDG PET Image Study#1114102
- Deep Brain Stimulation for Refractory Major Depression#877081
Record · ID 832299
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive